메뉴 건너뛰기




Volumn 46, Issue 3, 2011, Pages 415-416

Induction of microsomal triglyceride transfer protein expression is a candidate mechanism by which ezetimibe therapy might exert beneficial effects in patients with nonalcoholic steatohepatitis

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE BINDING PROTEIN; CHOLESTEROL; EZETIMIBE; GLUCOSE REGULATED PROTEIN 78; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; NIEMANN PICK C1 LIKE 1 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG;

EID: 79954415297     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0356-8     Document Type: Letter
Times cited : (8)

References (6)
  • 1
    • 78651473467 scopus 로고    scopus 로고
    • Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
    • 20658156 10.1007/s00535-010-0291-8 1:CAS:528:DC%2BC3MXmsV2qtQ%3D%3D
    • H Park T Shima K Yamaguchi H Mitsuyoshi M Minami K Yasui, et al. 2011 Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease J Gastroenterol 46 101 107 20658156 10.1007/s00535-010-0291-8 1:CAS:528:DC%2BC3MXmsV2qtQ%3D%3D
    • (2011) J Gastroenterol , vol.46 , pp. 101-107
    • Park, H.1    Shima, T.2    Yamaguchi, K.3    Mitsuyoshi, H.4    Minami, M.5    Yasui, K.6
  • 3
    • 79954414595 scopus 로고    scopus 로고
    • Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet
    • Epub ahead of print
    • Muraoka T, Aoki K, Iwasaki T, Shinoda K, Nakamura A, Aburatani H, et al. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet. Metabolism [Epub ahead of print].
    • Metabolism
    • Muraoka, T.1    Aoki, K.2    Iwasaki, T.3    Shinoda, K.4    Nakamura, A.5    Aburatani, H.6
  • 4
    • 70350468701 scopus 로고    scopus 로고
    • Inhibition of hepatic Neiman-Pick C1-Like 1 Improves hepatic insulin resistance
    • Epub ahead of print
    • Nomura M, Ishii H, Kawakami A, Yoshida M. Inhibition of hepatic Neiman-Pick C1-Like 1 Improves hepatic insulin resistance. Am J Physiol Endocrinol Metab [Epub ahead of print].
    • Am J Physiol Endocrinol Metab
    • Nomura, M.1    Ishii, H.2    Kawakami, A.3    Yoshida, M.4
  • 5
    • 77954366025 scopus 로고    scopus 로고
    • Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study
    • 20412324 10.1111/j.1872-034X.2010.00644.x
    • M Yoneda K Fujita Y Nozaki H Endo H Takahashi K Hosono, et al. 2010 Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: an open-label, pilot study Hepatol Res. 40 613 621 20412324 10.1111/j.1872-034X. 2010.00644.x
    • (2010) Hepatol Res. , vol.40 , pp. 613-621
    • Yoneda, M.1    Fujita, K.2    Nozaki, Y.3    Endo, H.4    Takahashi, H.5    Hosono, K.6
  • 6
    • 70349249503 scopus 로고    scopus 로고
    • Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis
    • 19650159 10.1002/hep.23094 1:CAS:528:DC%2BD1MXhtFKntL%2FO
    • K Fujita Y Nozaki K Wada M Yoneda Y Fujimoto M Fujitake, et al. 2009 Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis Hepatology. 50 772 780 19650159 10.1002/hep.23094 1:CAS:528:DC%2BD1MXhtFKntL%2FO
    • (2009) Hepatology. , vol.50 , pp. 772-780
    • Fujita, K.1    Nozaki, Y.2    Wada, K.3    Yoneda, M.4    Fujimoto, Y.5    Fujitake, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.